The effect of Acomplia® (rimonabant) on esophageal sensitivity and gastric accommodation during food intake in healthy volunteers: a single-blind, placebo-controlled study - Effec Acomplia gastric sensitivity

ZLeuven0 个研究点目标入组 10 人开始时间: 2011年8月9日最近更新: 2021年3月8日

适应症

试验速览

暂无简介。

•Healthy volunteers will be recruited from an existing mailing list. The volunteers will have to agree to participate in both studies as described below. In total 10 healthy volunteers (18-45 years) will be recruited
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 10
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Subjects are excluded from participation if:
•Their age is not between 18 and 45 years old.
•They have relevant underlying disease (cardia, pulmonary, metabolic, kidney or liver disease, … )
•They have a history of esophageal or gastric surgery, or recurrent or intermittent upper gastrointestinal symptoms (upper abdominal pain, nausea, vomiting, bothersome fullness or early satiation, heartburn, regurgitation,…)
•They have a history of allergy to several types of drugs or food.
•They have ever been treated for depression or had episodes of depression (using validated tests)
•They use cannabinoids.
•There is a possibility of becoming pregnant during the study period.
•Body mass index > 25

发起方

ZLeuven